MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations-Reference-Cited by-同舟云学术

MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations

Published:2024-08-22 Issue: Volume: Page:
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Elbarbary Nancy¹^ORCID,Alguwaihes Abdullah²³^ORCID,Zarif Hawazen⁴⁵,Hassanein Mohamed⁶⁷,Deeb Asma⁸⁹,Petrovski Goran¹⁰¹¹^ORCID,Al Dahash Raed¹²¹³,Alamoudi Reem¹⁴,Hussain Sufyan¹⁵¹⁶¹⁷,Ibrahim Mahmoud¹⁸^ORCID,Shaikh Shehla¹⁹,Zainudin Sueziani Binte²⁰,Chaar Wael²¹^ORCID,van den Heuvel Tim²²,Al-Sofiani Mohammed E.²²³^ORCID

Affiliation:

1. Diabetes and Endocrinology Unit, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

2. Division of Endocrinology, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

3. Diabetes Center, Dallah Hospital, Riyadh, Saudi Arabia.

4. Endocrinology section, Department of Medicine, King Abdulaziz Medical City, King Abdullah International Medical Research Centre, Ministry of National Guards Health Affairs, Jeddah, Saudi Arabia.

5. College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.

6. Endocrine Department, Dubai Hospital, Dubai Academic Health Cooperation, Dubai, United Arab Emirates.

7. College of Medicine, Mohamed Bin Rashid University, Dubai, United Arab Emirates.

8. Paediatric Endocrinology Division, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.

9. College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates.

10. Division of Endocrinology, Department of Pediatric Medicine, Sidra Medicine, Doha, Qatar.

11. College of Medicine, Weill Cornell Medicine, Doha, Qatar.

12. Department of medicine, king Abdulaziz medical city-National Guard health Affairs, Riyadh, Saudi Arabia.

13. Department of medicine, King Saud Bin Abdulaziz for Health Science University, Riyadh, Saudi Arabia.

14. Department of Medicine, King Abdulaziz Medical City, King Abdullah International Research Centre, Ministry of National Guards Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.

15. Department of Diabetes and Endocrinology, Guy’s & St Thomas’ NHS Foundation Trust, London, United Kingdom.

16. Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King’s College London, London, United Kingdom.

17. Institute of Diabetes, Endocrinology and Obesity, King’s Health Partners, London, United Kingdom.

18. EDC Center for Diabetes Education, Charlotte, North Carolina, USA.

19. Department of Diabetology & Endocrinology, Saifee Hospital, Mumbai, India.

20. Department of Endocrinology, Department of General Medicine, Sengkang General Hospital, Singapore, Singapore.

21. Clinical Research and Medical Science, Medtronic Saudi Arabia, Riyadh, Saudi Arabia.

22. Diabetes Operating Unit, Medtronic International Trading Sarl, Tolochenaz, Switzerland.

23. Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University, Baltimore, Maryland, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2024.0200

Reference34 articles.

1. Diabetes and Ramadan: Practical guidelines 2021

2. Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey

3. Attitude, complications, ability of fasting and glycemic control in fasting Ramadan by children and adolescents with type 1 diabetes mellitus

4. Diabetes among Muslims during Ramadan: A narrative review

5. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition